Skip to Content

B855 (Repaglinide 2 mg)

Pill with imprint B855 is Red, Round and has been identified as Repaglinide 2 mg. It is supplied by Breckenridge Pharmaceutical, Inc..

Repaglinide is used in the treatment of diabetes, type 2 and belongs to the drug class meglitinides. Risk cannot be ruled out during pregnancy. Repaglinide 2 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for B855

Repaglinide

Imprint:
B855
Strength:
2 mg
Color:
Red
Shape:
Round
Availability:
Prescription only
Drug Class:
Meglitinides
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Breckenridge Pharmaceutical, Inc.
National Drug Code (NDC):
51991-0855

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide